Status:
NOT_YET_RECRUITING
Diagnostic Value of Serum Cathepsin S and Chromogranin A in DKD
Lead Sponsor:
Assiut University
Conditions:
Diabetic Kidney Disease
Eligibility:
All Genders
20-80 years
Brief Summary
1. Evulate the diagnostic value of serum cathepsin S and chromogranin A for Diabetic kidney disease. 2. To correlate the levels of serum Cathepsin S and chromogranin A with HbA1c and eGFR in type 2 di...
Detailed Description
Diabetic nephropathy (DN) is a common and serious complication of diabetes and has been shown to be a major cause of end-stage renal disease (ESRD), requiring costly renal replacement therapy in the f...
Eligibility Criteria
Inclusion
- patients diagnosed as type 2 Diabetes mellitus
- Patients with T2DM with normoalbuminuria , microalbuminuria and macroalbuminuria.
Exclusion
- Renal impairment of other Known origin,
- Type 1 D,
- Hepatic disease,
- Heart failure,
- Thyroid disorders,
- Autoimmune disorders,
- Inflammatory condition,
- Malignancy,
- Urinary tract infection,
- Pregnancy.
Key Trial Info
Start Date :
November 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
92 Patients enrolled
Trial Details
Trial ID
NCT06069076
Start Date
November 1 2023
End Date
October 1 2026
Last Update
October 13 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.